Suresnes, France (ots/PRNewswire) - - Servier reported Group revenues of €6.9 billion for 2024/25, up 16.2% from 2023/24. - Growth over the financial year was driven by increased sales in oncology, particularly in the United States. - Several partnership agreements in oncology and neurology strengthen the Group's R&D portfolio in rare diseases. - Achieving 2025 ...
Tübingen, Germany (ots) - Acousia Therapeutics GmbH, a clinical-stage biotechnology company developing treatments for acute and chronic inner ear hearing loss, announced the completion of patient enrollment in its Phase 2 PROHEAR clinical study. ACOU085 (INN: Bimokalner) is a proprietary, first-in-class small ...
STADA obtains approvals to bring denosumab biosimilars in bone-health and oncology to patients in Europe - European Commission approves STADA’s Kefdensis® and Zvogra® denosumab biosimilars for all indications of reference medicines Prolia® and ...
Asklepios Kliniken GmbH & Co. KGaA
Wiesbaden, Germany (ots) - - Dr. Carl June and Dr. Michel Sadelain honored for groundbreaking CAR-T cell research in cancer therapy - One of the world’s most highly endowed medical prizes, with €1 million in prize money, awarded for the first time - Titia große Broermann: “With the Broermann Medical Innovation Award, we want to make outstanding medical ...
Dresden (ots) - - Oversubscribed financing round consisting of €77 million in Series C equity capital, led by HV Capital and DTCF, and €23 million in public funding, marking one of the largest capital rounds in the European semiconductor sector - Fresh capital accelerates the commercialization of FMC DRAM+ and 3D CACHE+ memory chips to enable the global ramp-up of ...
Technische Universität München
TECHNICAL UNIVERSITY OF MUNICH NEWS RELEASE New method for the targeted production of specific cells Nanorobots transform stem cells into bone cells - Mechanical stimulation can transform stem cells into bone cells. - Researchers have demonstrated that cells can be reliably transformed in a system using nanorobots and laser light. - In principle this method can also be used to produce heart and cartilage cells. For the ...
Berlin, Germany (ots) - Sentorise has launched its 12.8V 100Ah Group 31 LiFePO₄ battery in Europe, providing a reliable power solution for RV travelers, off-grid homes, and marine users. With long life, built-in safety, and smart monitoring, it’s designed for dependable off-grid and backup energy. It’s the first in Europe to offer full-series low-temperature ...
Zurich (ots) - Vaccentis, a Zurich based biotech company specializing in the development of therapeutic protein-based tumor vaccines, has signed a letter of intent with TrueMed, a leading commercialization partner. Accelerating cancer vaccine against renal cell carcinoma The aim of this letter of intent is to ...
Fraunhofer-Institut für Produktionstechnologie IPT
Leipzig (ots) - Kerry, a global leader in taste and nutrition, has today inaugurated the Kerry Biotechnology Centre in Leipzig, Germany, which will focus on the development of innovative biotech solutions across food, beverage, and pharma applications. New capabilities in biotechnology are opening the field to ...
Asklepios Kliniken GmbH & Co. KGaA
Technische Universität München
TECHNICAL UNIVERSITY OF MUNICH NEWS RELEASE Hollow microparticles for cargo molecules Slime as a material for multifunctional spheres - Hollow microspheres for molecular cargoes combine multiple functions - They adhere effectively to soft tissue and cartilage - Potential future applications in osteoarthritis or for oral ulcers Researchers at the Technical University of Munich (TUM) have developed hollow microspheres made ...
Brussels (ots/PRNewswire) - - 26 scientific abstracts, including two oral presentations, demonstrate UCB's ongoing commitment to advancing research for people living with epilepsies - Data include an open-label extension study describing the long-term safety of FINTEPLA®▼ (fenfluramine)[1] and global functioning ...
DHL Group erzielt Ergebniswachstum im zweiten Quartal 2025 - Konzernumsatz sinkt durch Wechselkurseffekte und ein geringeres Momentum der Handelsvolumen im zweiten Quartal um 3,9 Prozent auf 19,8 Milliarden Euro (Q2 2024: 20,6 Milliarden Euro) - EBIT ...
Many people with cancer experience dramatic loss of muscle and fat tissue. In many cases, even the heart muscle is affected, which further weakens the body. This wasting syndrome, known as cachexia, affects around half of all cancer patients. It is a major cause of therapy resistance, complications, and increased mortality. ...
New York and North Chicago, Ill. (ots/PRNewswire) - - ISB 2001 is currently in Phase 1 clinical trial in patients with relapsed/refractory multiple myeloma (R/R MM) IGI Therapeutics SA, a wholly owned subsidiary of New York-based Ichnos Glenmark Innovation, Inc. (IGI), and AbbVie (NYSE: ABBV) today announced an ...
Fraunhofer-Institut für Produktionstechnologie IPT
LONGi Green Energy Technology Co., Ltd.
